| 000 | 02641 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250513234641.0 | ||
| 264 | 0 | _c20010524 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood.v97.8.2390 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFortin, J F | |
| 245 | 0 | 0 |
_aRegulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. _h[electronic resource] |
| 260 |
_bBlood _cApr 2001 |
||
| 300 |
_a2390-400 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aActive Transport, Cell Nucleus |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xphysiology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHIV Long Terminal Repeat _xphysiology |
| 650 | 0 | 4 |
_aHIV-1 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-1 _xgenetics |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aIonomycin _xpharmacology |
| 650 | 0 | 4 |
_aJurkat Cells _xdrug effects |
| 650 | 0 | 4 |
_aLymphocyte Specific Protein Tyrosine Kinase p56(lck) _xdeficiency |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 | _aNFATC Transcription Factors |
| 650 | 0 | 4 | _aNuclear Proteins |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPhytohemagglutinins _xpharmacology |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 | _aProtein Tyrosine Phosphatase, Non-Receptor Type 6 |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xphysiology |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aTranscription Factors _xphysiology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aZAP-70 Protein-Tyrosine Kinase |
| 700 | 1 | _aBarbeau, B | |
| 700 | 1 | _aRobichaud, G A | |
| 700 | 1 | _aParé , M E | |
| 700 | 1 | _aLemieux, A M | |
| 700 | 1 | _aTremblay, M J | |
| 773 | 0 |
_tBlood _gvol. 97 _gno. 8 _gp. 2390-400 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.v97.8.2390 _zAvailable from publisher's website |
| 999 |
_c11225876 _d11225876 |
||